4.5 Article

Vitamin D: Evidence for its role as a prognostic factor in multiple sclerosis

Journal

JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 311, Issue 1-2, Pages 19-22

Publisher

ELSEVIER
DOI: 10.1016/j.jns.2011.06.035

Keywords

Multiple sclerosis; Vitamin D; Relapse; Disability; Randomized controlled trial

Funding

  1. National Multiple Sclerosis Society
  2. [NIHK23NS067055]

Ask authors/readers for more resources

Vitamin D insufficiency has been shown to be associated with increased susceptibility to multiple sclerosis (MS), but until recently, it was unclear if vitamin D status also influences the prognosis of the disease. In experimental autoimmune encephalomyelitis, a mouse model of MS, the administration of vitamin D reduces the severity of the disease. Initial reports in MS of inverse associations between vitamin D levels and disability or relapse rate were encouraging, but the cross-sectional or retrospective study designs limited their interpretability. More recently, studies of pediatric-onset and adult MS have demonstrated that among those with established MS, those with lower vitamin D levels are at higher risk for subsequent relapse. These observational data provide strong support for randomized controlled trials of vitamin D supplementation in MS. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available